期刊文献+

冠状动脉造影术后造影剂肾病的危险因素分析 被引量:1

Risk factors of contrast-induced nephropathy in patients after coronary angiography
原文传递
导出
摘要 目的探讨冠状动脉造影术后造影剂肾病(CIN)发生的相关危险因素。方法选择200例行冠状动脉造影患者为研究对象,根据患者术后48~72h是否发生CIN分为CIN组和非CIN组,对其CIN发生的相关危险因素进行分析。结果200例行冠状动脉造影患者中有13例发生CIN,CIN发生率为6.5%(13/200)。Logistic回归分析显示原有肾功能不全、糖尿病、造影剂剂量及高龄与CIN的发生有关(P〈0.05)。结论原有肾功能不全、糖尿病、造影剂剂量及高龄是冠状动脉造影术后CIN发生的危险因素。 Objective To investigate the risk factors of contrast-induced nephropathy (CIN) in patients after coronary angiography. Methods Two hundred patients underwent coronary angiography were enrolled in this study. The patients were divided into CIN group and non-CIN group according to the occurrence of CIN after coronary angiography of 48 - 72 h,and then the related risk factors of CIN were analyzed. Results Thirteen eases of CIN were found in 200 patients, and the occurrence rate was 6.5% (13/200). logistic regression analysis showed that risk factors of CIN included primary renal insufficiency, diabetes, contrast agent dose and advanced age (P 〈 0.05). Conclusion Primary renal insufficiency, diabetes, contrast agent dose and advanced age are risk factors of CIN in patients after coronary angiography.
作者 程谦 王琳
出处 《中国医师进修杂志》 2013年第10期4-6,共3页 Chinese Journal of Postgraduates of Medicine
关键词 危险因素 造影剂肾病 冠状动脉造影 Risk factors Contrast-induced nephropathy Coronary angiography
  • 相关文献

参考文献2

二级参考文献27

  • 1陈钟,黄华,吴振宇,祝文彩,李根喜.95%肝切除与药物诱导大鼠急性肝衰竭模型的比较[J].中国普通外科杂志,2005,14(1):32-35. 被引量:8
  • 2Li-MaoWu,Lian-DaLi,HongLiu,Ke-YongNing,Yi-KuiLi.Effects of Guiyuanfang and autologous transplantation of bone marrow stem cells on rats with liver fibrosis[J].World Journal of Gastroenterology,2005,11(8):1155-1160. 被引量:7
  • 3李亚明,张晶,赵军,陈煜,段钟平.急性肝功能哀竭动物模型的建立[J].肝脏,2006,11(3):175-177. 被引量:9
  • 4Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coil Cardiol, 2004,44(9) : 1780-1785.
  • 5Davidson CJ, Laskey WK, Hermiller JB, et al, Randomized trial of contrast media ufihzafion in high-risk PTCA:the COURT trial. Circulation, 2000,101 ( 18 ) : 2172-2177.
  • 6Cigarroa RG,Lange RA ,Williams RH ,et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med, 1989,86(6 Pt 1 ) :649-652.
  • 7Rihal CS,Textor SC ,Grill DE,et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002,105( 19 ) : 2259-2264.
  • 8Jujo K,Yamaguchi J,Ohayashi K,et al. Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial, infarction undergoing emergent coronary angiography. J Cardiol, 2006,48 ( 1 ) :9-16.
  • 9Toprak O, Conflicting and new risk factors for contrast induced nephropathy, J Urol, 2007,178 (6) : 2277-2283.
  • 10Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv, 2008,71 ( 1 ) : 62-72.

共引文献12

同被引文献4

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部